Definitive Healthcare Corp Stock Price To Book
| DH Stock | USD 4.93 0.08 1.60% |
Definitive Healthcare Corp fundamentals help investors to digest information that contributes to Definitive Healthcare's financial success or failures. It also enables traders to predict the movement of Definitive Stock. The fundamental analysis module provides a way to measure Definitive Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Definitive Healthcare stock.
The current Price To Book Ratio is estimated to decrease to 1.42. Definitive | Price To Book |
Definitive Healthcare Corp Company Price To Book Analysis
Definitive Healthcare's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Definitive Healthcare Price To Book | 1.14 X |
Most of Definitive Healthcare's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Definitive Healthcare Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Definitive Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for Definitive Healthcare is extremely important. It helps to project a fair market value of Definitive Stock properly, considering its historical fundamentals such as Price To Book. Since Definitive Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Definitive Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Definitive Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Definitive Price To Book Historical Pattern
Today, most investors in Definitive Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Definitive Healthcare's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to book growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Definitive Healthcare price to book as a starting point in their analysis.
Definitive Healthcare Price To Book |
| Timeline |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Definitive Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, Definitive Healthcare Corp has a Price To Book of 1.1427 times. This is 95.55% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The price to book for all United States stocks is 87.98% higher than that of the company.
Definitive Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Definitive Healthcare's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Definitive Healthcare could also be used in its relative valuation, which is a method of valuing Definitive Healthcare by comparing valuation metrics of similar companies.Definitive Healthcare is currently under evaluation in price to book category among its peers.
Definitive Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Definitive Healthcare from analyzing Definitive Healthcare's financial statements. These drivers represent accounts that assess Definitive Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Definitive Healthcare's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 4.2B | 2.7B | 1.1B | 1.1B | 1.3B | 1.2B | |
| Enterprise Value | 4.6B | 2.5B | 1.2B | 1.3B | 1.4B | 1.4B |
Definitive Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Definitive Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Definitive Healthcare's managers, analysts, and investors.Environmental | Governance | Social |
Definitive Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0076 | ||||
| Profit Margin | (1.42) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 530.57 M | ||||
| Shares Outstanding | 115.52 M | ||||
| Shares Owned By Insiders | 3.80 % | ||||
| Shares Owned By Institutions | 95.30 % | ||||
| Number Of Shares Shorted | 2.1 M | ||||
| Price To Book | 1.14 X | ||||
| Price To Sales | 2.26 X | ||||
| Revenue | 251.41 M | ||||
| Gross Profit | 216.68 M | ||||
| EBITDA | (241.23 M) | ||||
| Net Income | (202.39 M) | ||||
| Cash And Equivalents | 347.87 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 267.93 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 3.32 X | ||||
| Book Value Per Share | 4.39 X | ||||
| Cash Flow From Operations | 41.19 M | ||||
| Short Ratio | 5.53 X | ||||
| Earnings Per Share | (3.09) X | ||||
| Price To Earnings To Growth | 1.03 X | ||||
| Target Price | 5.25 | ||||
| Number Of Employees | 950 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 578.77 M | ||||
| Total Asset | 1.83 B | ||||
| Retained Earnings | (227.45 M) | ||||
| Working Capital | 223.25 M | ||||
| Net Asset | 1.83 B |
About Definitive Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Definitive Healthcare Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Definitive Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Definitive Healthcare Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Definitive Healthcare Piotroski F Score and Definitive Healthcare Altman Z Score analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.